UP!

HNSN $3.99

HNSN target price
3.99
0
0
Hansen Medical, Inc.
Type
Intravascular Robotics
Traded as NASDAQ: HNSN
Industry Medical Appliances & Equipment
Founded 2002 (2002)
Headquarters Mountain View, California, U.S.
Key people
Cary Vance (CEO)
Products Sensei Robotic System and Magellan Robotic System
Website www.hansenmedical.com

Hansen Medical, Inc, headquartered in Mountain View, California, designs and manufactures medical robotics for positioning and control of catheter-based technologies that was founded in 2002 by Frederic Moll, M.D. to develop tools that manipulate catheters by combining robotic technology and computerized movement.

In 2005, Hansen bought EndoVia Medical Inc., a medical robotics company.

Later that year, Hansen Medical and Intuitive Surgical, another company founded by Moll, entered into a cross-licensing agreement that included Hansen's portfolio of 50 issued and pending patents and patent applications and Intuitive's 250 issued patents related to minimally invasive instruments and surgical robotics.

Hansen Medical went public in 2006, raising $75 million in its Initial Public Offering with two catheter systems under FDA review. The shares represented about 30% of the company.

In July 2016 it was acquired by Auris Surgical Robotics, and it was said to be a $80 million merger.

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

9014-03-21
8795-03-19
5293-02-14
4517-03-09
3270-03-31
3062-02-26
2011-09-01 Initiated Ladenburg Thalmann Buy $4.50
2011-07-18 Reiterated C.K. Cooper Buy $4 to $5.30
2011-06-30 Upgrade Piper Jaffray Neutral to Overweight $3 to $5
2011-03-01 Initiated C.K. Cooper Buy $3
2010-05-14 Downgrade Brean Murray Buy to Hold
2009-12-10 Upgrade Brean Murray Hold to Buy $4.50
2009-09-15 Downgrade Argus Hold to Sell
2009-07-07 Downgrade Brean Murray Buy to Hold
2009-02-24 Initiated JMP Securities Mkt Perform
2009-01-09 Reiterated Lazard Capital Buy $18 to $8
2008-08-01 Downgrade Merriman Curhan Ford Buy to Neutral
2008-06-04 Initiated SMH Capital Neutral
2008-05-02 Reiterated Leerink Swann Outperform $45 to $30
1970-01-01
1643-03-07
9014-03-21
8795-03-19
5293-02-14
4517-03-09
3270-03-31

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In HNSN 0 funds of 2213 total. Show all

Fund name Ticker shares

Major Shareholders

Name Relationship Total Shares Holding stocks
SCHULER JACK W 11.80%  (13233640) AXDX / BIOL / GTXI / HNSN / MBLX / MDT / QDEL / SRCL / VRML /
WEINSTEIN WILL K 1.09%  (1217755) HNSN /
BARCLAY BRUCE President and CEO 0.19%  (211286) HNSN / SMLR /
Sutton William Mitchell Chief Operating Officer 0.02%  (25000) HNSN /
Bruguera Carolyn M VP, General Counsel 0.01%  (9110) HNSN /
Schembri Frank M. Jr. Vice President Manufacturing 0.01%  (7092) HNSN /